Salem, WV, United States of America

Dennis J Kubek

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Merck + Co., Inc.. Active years: 1989-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis J Kubek. Retrieved from https://idiyas.com/inventor/dennis-j-kubek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 163(Granted Patents)


Location History:

  • Lansdale, PA (US) (1989)
  • Harleysville, PA (US) (1992)
  • Salem, WV (US) (1997 - 1998)

Company Filing History:


Years Active: 1989-1998

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Dennis J Kubek

Introduction

Dennis J Kubek is a notable inventor based in Salem, WV (US). He has made significant contributions to the field of vaccine development, particularly in relation to Streptococcus pneumoniae. With a total of 4 patents, his work has had a profound impact on public health.

Latest Patents

One of his latest patents is focused on a process for making capsular polysaccharides from Streptococcus pneumoniae. This innovative method produces type-specific capsular polysaccharide preparations that have on average less than about 1000 oligosaccharide repeat units per molecule. The polydispersities range between 1.0 and 1.4, with intrinsic viscosities between 0.6 and 3.0 dL/g, and less than 3% contamination of type-specific polysaccharide by group-specific C-polysaccharide. These novel type-specific polysaccharide products are particularly useful in the preparation of vaccines, especially covalent conjugates linked to T-cell stimulatory carrier proteins. Another significant patent involves a pneumococcal polysaccharide conjugate vaccine, which comprises partially hydrolyzed, highly purified capsular polysaccharide linked to an immunogenic carrier protein. This conjugate is effective in preventing pneumococcal infections and induces protective immune responses in young children and infants who typically cannot mount a protective immune response to the polysaccharide alone.

Career Highlights

Dennis J Kubek is currently associated with Merck & Company, Inc., where he continues to innovate in the field of vaccine research. His work has been instrumental in developing new methods and products that enhance vaccine efficacy and safety.

Collaborations

He has collaborated with notable colleagues such as Peter J Kniskern and William J Miller, contributing to the advancement of vaccine technology.

Conclusion

Dennis J Kubek's contributions to vaccine development and his innovative patents have significantly advanced the field of immunology. His work continues to play a crucial role in the prevention of infections caused by Streptococcus pneumoniae.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…